RxDoctor Payments Data

Erica Wilt

Nurse Practitioner · Piqua, OHNPI 1174948376

Payments from drug & device makers

$1,080in general payments, 2019–2025

Across 72 payments — averaging $15.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$233
  • AstraZeneca$156
  • Pfizer$155
  • Lilly USA, LLC$135
  • GSK$104
  • Boehringer Ingelheim$58
  • plus $239 from 8 others

What the payments were for

  • Food & beverage$1,080100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,080 in reported general payments places this provider in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$35,360
Medicare patients
152
Services billed
1,062

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$34,504
JardianceEmpagliflozin34$32,489
TrulicityDulaglutide13$26,830
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$23,212
FarxigaDapagliflozin Propanediol13$17,300
EliquisApixaban15$12,161
JanumetSitagliptin Phos/Metformin Hcl15$12,099
Breo ElliptaFluticasone/Vilanterol23$9,222
Advair HfaFluticasone Propion/Salmeterol20$8,717
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,592
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$6,868
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,242
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,715
Duloxetine Hcl77$1,945
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$1,868

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$104$37,67768 claims
Novo NordiskOzempic$45$34,50428 claims
Boehringer IngelheimJardiance$58$32,48934 claims
Lilly USA, LLCTrulicity$135$26,83013 claims
AstraZenecaFarxiga, Breztri Aerosphere$156$24,89225 claims
PfizerEliquis$155$12,16115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Piqua

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →